Myeloma Matters Podcast | Relapsed/Refractory Multiple Myeloma

In this episode, we tackle the difficult topic of what happens when a patient’s treatment doesn’t work or stops working. You’ll hear from three patients who’ve faced this situation and learn how they navigated the process of making decisions about their treatments, including how they approached discussions with their health care team to determine the best plan for this new stage of their diagnosis.
Topics of discussion:
·18:50 Emotional impact of relapse
·23:50 Deciding on a treatment regimen
·31:56 Managing side effects
·35:35 The role of an autologous stem cell transplant
·48:48 Consideration of a clinical study
This episode is supported by AbbVie, Amgen, Bristol Myers Squibb, CURE, Genentech, GSK, Janssen, Karyopharm, Sanofi, and Takeda.
To learn more about multiple myeloma, visit themmrf.org/.
If you have additional questions, call the MMRF Patient Navigation Center at 1-888-841- 6673.

[@weekenddistractions]

This was a greatly helpful and informative podcast.

[@uj3185]

promo sm 😠